Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections - Wikidata - awgldk - TriplyDB

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections

http://www.wikidata.org/entity/Q35676296

about

Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia.Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model CdtR Regulates TcdA and TcdB Production in Clostridium difficile Clostridium difficile colitis: pathogenesis and host defence Clostridium difficile Toxin A Undergoes Clathrin-Independent, PACSIN2-Dependent Endocytosis A genetic switch controls the production of flagella and toxins in Clostridium difficile Regulation of Clostridium difficile spore germination by the CspA pseudoprotease domain Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer.Surviving Between Hosts: Sporulation and Transmission.Bacterial glycosyltransferase toxins.Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model.Recombinant Mucin-Type Fusion Proteins with a Galα1,3Gal Substitution as Clostridium difficile Toxin A Inhibitors.Pathogenic effects of glucosyltransferase from Clostridium difficile toxins.Host response to Clostridium difficile infection: Diagnostics and detection.Current knowledge on the laboratory diagnosis of Clostridium difficile infection.Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternative.Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms.SNP-ing out the differences: Investigating differences between Clostridium difficile lab strains.Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.Fidaxomicin and OP-1118 inhibit C. difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-κB activity.Inactivation of the dnaK gene in Clostridium difficile 630 Δerm yields a temperature-sensitive phenotype and increases biofilm-forming ability.A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells.The role of toxins in Clostridium difficile infection.The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.GeneGini: Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and Diverse Human Transporter Expression Profiles.Treatment of recurrent Clostridium difficile colitis: a narrative review.Clostridium difficile Toxins A and B Decrease Intestinal SLC26A3 Protein Expression.A Rapid, Accurate, Single Molecule Counting Method Detects Clostridium difficile Toxin B in Stool Samples.Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.Clostridium sordellii outer spore proteins maintain spore structural integrity and promote bacterial clearance from the gastrointestinal tract.Cysteine Protease-Mediated Autocleavage of Clostridium difficile Toxins Regulates Their Proinflammatory Activity.Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile.Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection Novel Clade C-I Clostridium difficile strains escape diagnostic tests, differ in pathogenicity potential and carry toxins on extrachromosomal elements

P2860

Q26751477-BD477A75-62E5-449D-A910-CA9D814E7833 Q26776411-8EC859B8-DDA9-4388-AE01-5338E99A15BD Q27332358-7D63922C-E8D5-4467-ADA1-C52B11F40704 Q30276036-7EE9198A-D74A-4330-B4F3-ABD7A15205F1 Q30276645-D61EB7E4-1DFA-4212-BC85-10ACF9E82370 Q33920445-F9C7948D-EBC4-40B9-9BA0-4A9B8DBF561D Q36060123-43AAD9EE-6279-477C-A928-842BC1EE77BB Q36077222-CB94092D-A367-4735-B221-8429E8A0A098 Q36116428-AD9169E8-4292-4562-9A64-F0CBBA7043B8 Q36220118-4C8BAE5F-63A4-496E-B750-59C5938C8993 Q36323846-915C87AA-1732-4A8E-AE91-387B9DBA8ECA Q36520610-4378A3C0-8EC3-4585-873F-7383CD97B873 Q36631348-FE8331BB-BC80-4E61-9B74-E67622D79926 Q36823908-78DE25EE-5DE9-41EF-8326-30B7A0B0098B Q37336501-DBA7A9D5-2473-469F-84D8-A72F5379574F Q38601591-00FC320F-2977-4D0C-B39C-1BC20B26938D Q38633032-52A0BF7D-AA8C-4BE0-B138-DE1A1186FB91 Q38755916-5A018AD5-C605-4376-9C04-243706AAC13A Q38797967-C2FD5D81-D2F6-4FAB-A2A3-EDD2F97DD0BC Q38969987-E7118464-8BD8-4868-845D-1F9F6CF30896 Q39188881-DA98ECFA-A2A7-4A15-AE82-DDF7EDC94FD6 Q40169068-FBB28339-9205-4D87-A3A9-85DB41D430D1 Q41193374-B0A8477A-C35D-4DA9-8206-2A75C74E7C3E Q42072636-8D778205-0190-4BE5-8D1A-570D75A10ED9 Q43167690-2F835108-19A4-4A19-BC3B-9B2D62C6B86B Q46412261-2890AC3B-30E2-4D7A-9600-C66ED894931B Q47117559-1F5EC030-1555-48E8-9A5D-E7F186BB8E8C Q47694597-DF2B74D2-F5D1-44AA-BA31-92AFFDB331EF Q47734724-3EAB5CD8-0E05-4C39-BF40-B985BB133488 Q49282081-AC75612D-A915-44E0-8F90-B21D21128CFD Q50083195-D27C97B6-A48D-47AF-93D4-4F77BCCEC088 Q50285268-FFDB9419-3902-4D35-8152-2A01F13402B1 Q52723167-DF5C1C2A-C105-471F-9F00-BBFDEB59AA8F Q54985770-1C1D6C5D-D238-4122-AB48-FC523F307B54 Q55103812-37E78CC1-A346-4F70-9CE5-F930F686D0B9 Q55247783-5EF91F46-DFF2-44A5-B948-24FD91819D6C Q55279053-39A0B549-9CEA-4B7A-9284-D3F07E9355F4 Q55422865-FF068761-5D13-4E6A-B3BA-0CB46513D4F4 Q57107809-BC54B45F-0E81-49CF-84EF-A97417F1BCE2 Q58733765-DE81A11A-A8C9-4456-8405-87BC9D23F62C

P2860

Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections

http://www.wikidata.org/entity/Q35676296

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Defining the Roles of TcdA and ...... ostridium difficile Infections

@ast

Defining the Roles of TcdA and ...... ostridium difficile Infections

@en

type

label

Defining the Roles of TcdA and ...... ostridium difficile Infections

@ast

Defining the Roles of TcdA and ...... ostridium difficile Infections

@en

prefLabel

Defining the Roles of TcdA and ...... ostridium difficile Infections

@ast

Defining the Roles of TcdA and ...... ostridium difficile Infections

@en

P1433

Q35676296-53A8C8E7-0765-4F10-81FD-6EE2F8F5F5C2

P1476

Q35676296-DFB753F5-ACE8-4D35-988C-090B281D6232

P2093

Q35676296-36590AE5-8CCD-4608-9DAA-8897EAC71EF1

Q35676296-37DB8BAD-22D5-4B71-B67A-F4279CAC3EE7

Q35676296-3F5E9A08-1676-45A4-991A-3B7AD4EFED4C

Q35676296-47BF1F7A-A1F0-4E0A-98FD-D6A0B80B2335

Q35676296-6686985F-F29E-44F4-8C25-99C86903E940

Q35676296-83C2CEFF-D6BA-4F4D-914D-9E8AE04823FD

Q35676296-9C56F352-E306-4210-B7CC-BC3E73262100

Q35676296-AA51FE0F-37B9-4160-928B-43D514855D94

Q35676296-AFD741FE-09F7-445E-BD33-DE236EEDEA26

Q35676296-B89CCC8A-043C-43F4-A593-36C64065D326

P2860

Q35676296-0277BABF-88D8-4C97-9CA0-729463565403

Q35676296-152EE87A-8379-496B-9455-8E9009411A59

Q35676296-1DA6A729-A7F5-493A-BD3A-5D9DD5948060

Q35676296-1DC45C07-AE55-4B8E-8123-5E5337BD71BE

Q35676296-28660B18-9388-4688-9408-4F7A9588CB3C

Q35676296-2D0EF5E4-A759-494D-9E22-574CC03C7351

Q35676296-307BA12E-08CD-41B5-B72A-CA27ECBE7D33

Q35676296-39FEDF31-B559-411A-B9EC-03A2C41F9AB0

Q35676296-3F70855B-68B8-4BCB-9210-4233C7BA2AFB

Q35676296-3FFEAAFB-D0F1-4614-867C-D6976579F8DF

P304

Q35676296-7FDF424F-2FE2-4CEC-BBCC-E5CDCDBE5758

P31

Q35676296-CCC5D5CF-9FF3-4BA1-A229-67B680BFE92A

P356

Q35676296-4A429132-AD75-41CD-B6B8-AEEE4F9A644F

P433

Q35676296-D2081B94-BB74-4F73-9824-7D7303B40EF4

P478

Q35676296-066055F8-11C6-466A-9BD4-8EC7A8E04455

P50

Q35676296-57239EF4-F44D-4872-975F-298B1BD9229F

Q35676296-5A7BAED7-E250-42A3-8344-FD9F7FB9EE2C

Q35676296-61A60DE0-EC93-4C14-A2F4-EA37B5FC28B7

Q35676296-A7805C20-19FC-4D73-97E7-12EFDDEC9BF8

Q35676296-A95AFF6F-BF23-41C2-AA7C-78BE4E0AD0C0

P577

Q35676296-8D72D274-B781-4458-BE70-5D685226718A

P698

Q35676296-CFBE1807-5ED8-4AC6-9027-F620E73E814A

P921

Q35676296-29F87A37-9210-4079-92AB-532AB33CE23D

P932

Q35676296-5E25D602-2B48-4B7E-B17D-9530828C3E00

P356

P1433

P1476

Defining the Roles of TcdA and ...... ostridium difficile Infections

@en

P2093

Adam Cheknis

http://www.w3.org/2001/XMLSchema#string

Anjana Chakravorty

http://www.w3.org/2001/XMLSchema#string

Dale Gerding

http://www.w3.org/2001/XMLSchema#string

Fernanda Schreiber

http://www.w3.org/2001/XMLSchema#string

Gordon Dougan

http://www.w3.org/2001/XMLSchema#string

Iris Figueroa

http://www.w3.org/2001/XMLSchema#string

Lucy Li

http://www.w3.org/2001/XMLSchema#string

Pauline Howarth

http://www.w3.org/2001/XMLSchema#string

Simon Clare

http://www.w3.org/2001/XMLSchema#string

Stuart Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Toxin B is essential for virulence of Clostridium difficile

Clostridium difficile infection in the community: a zoonotic disease?

Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria

The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction

Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis

The changing epidemiology of Clostridium difficile infections

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B

Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.

P304

e00551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MBIO.00551-15

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Bliss Cunningham

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26037121

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

4453007

http://www.w3.org/2001/XMLSchema#string